Research Catalog
Peptide materials and blends supplied for lawful laboratory, analytical and in-vitro research applications. Pricing is available to verified account holders who have accepted the current Research Use Terms.
GHK-Cu / BPC-157 / TB-500 Blend
This is a co-lyophilized research blend of GHK-Cu (a tripeptide-copper complex), BPC-157 (a synthetic pentadecapeptide), and TB-500 (a synthetic peptide fragment of Thymosin β4). It is supplied to support in-vitro and preclinical studies that characterize the three peptides together in extracellular-matrix, angiogenesis, and tissue-repair model systems. Component ratios per vial are provided in the analytical documentation for each batch. Supplied as a lyophilized powder for laboratory use. For research and analytical purposes only. Not for human, veterinary, or cosmetic use. No therapeutic, diagnostic, or clinical claims are made or implied. Content pending internal legal review.
KPV / GHK-Cu / BPC-157 / TB-500 Blend
This is a co-lyophilized research blend of KPV (a tripeptide corresponding to the C-terminal fragment of α-MSH, studied in the melanocortin-signaling and inflammatory-pathway literature), GHK-Cu (a tripeptide-copper complex), BPC-157 (a synthetic pentadecapeptide), and TB-500 (a Thymosin β4 fragment). It is supplied for in-vitro and preclinical studies that investigate the four peptides together across melanocortin-pathway, extracellular-matrix, and tissue-repair model systems. Component ratios per vial are provided in the analytical documentation for each batch. Supplied as a lyophilized powder for laboratory use. For research and analytical purposes only. Not for human, veterinary, or cosmetic use. No therapeutic, diagnostic, or clinical claims are made or implied. Content pending internal legal review.
Retatrutide
Retatrutide is a synthetic peptide characterized in the published preclinical literature as a triple agonist at the GLP-1, GIP, and glucagon receptors. It is used as a research reagent in in-vitro receptor-binding, cAMP-signaling, and preclinical metabolic-pathway assays that investigate incretin- and glucagon-receptor pharmacology in cultured cell and rodent model systems. Commonly used in academic metabolic-signaling research. Supplied as a lyophilized powder for laboratory use. For research and analytical purposes only. Not for human or veterinary consumption. No therapeutic, diagnostic, or clinical claims are made or implied. Content pending internal legal review.
BPC-157 / TB-500 Blend
This is a co-lyophilized research blend of BPC-157 (a 15-amino-acid synthetic pentadecapeptide) and TB-500 (a synthetic peptide corresponding to the active region of Thymosin β4). It is supplied to simplify in-vitro and preclinical work that investigates the two peptides together in tissue-repair, angiogenesis, and cell-migration model systems. Ratios and content per vial are provided in the analytical documentation for each batch. Supplied as a lyophilized powder for laboratory use. For research and analytical purposes only. Not for human or veterinary consumption. No therapeutic, diagnostic, or clinical claims are made or implied. Content pending internal legal review.
GHK-Cu Copper Peptide
GHK-Cu is a tripeptide-copper complex (glycyl-L-histidyl-L-lysine coordinated with Cu²⁺) that occurs endogenously in plasma. In published in-vitro literature it has been used as a research reagent to investigate copper-transport, extracellular-matrix remodeling, fibroblast activity, collagen and glycosaminoglycan expression, and antioxidant-response endpoints in cultured skin and connective-tissue cell models. It is commonly used in dermatological and cell-biology research assays. Supplied as a lyophilized powder for laboratory use. For research and analytical purposes only. Not for human, veterinary, or cosmetic use. No therapeutic, diagnostic, or clinical claims are made or implied. Content pending internal legal review.
MOTS-c
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region. In published in-vitro and preclinical rodent literature it has been used as a research reagent to investigate AMPK activation, glucose-uptake and insulin-sensitivity signaling, and mitochondrial metabolic endpoints in cultured skeletal-muscle and hepatocyte models. It is commonly used in academic bioenergetics and metabolic-signaling research assays. Supplied as a lyophilized powder for laboratory use. For research and analytical purposes only. Not for human or veterinary consumption. No therapeutic, diagnostic, or clinical claims are made or implied. Content pending internal legal review.
NAD+
NAD⁺ (nicotinamide adenine dinucleotide, oxidized form) is a coenzyme central to cellular redox reactions and a substrate for the sirtuin (SIRT) deacylase and PARP enzyme families. It is used as a research reagent in in-vitro biochemistry and cell-biology assays that characterize NAD⁺-dependent enzyme activity, cellular redox state, sirtuin-mediated signaling, and mitochondrial-metabolism endpoints. Commonly used in academic bioenergetics, longevity-pathway, and enzymology research. Supplied as a lyophilized powder for laboratory use. For research and analytical purposes only. Not for human or veterinary consumption. Not a dietary supplement. No therapeutic, diagnostic, or clinical claims are made or implied. Content pending internal legal review.
BPC-157
BPC-157 is a 15-amino-acid synthetic peptide sequence (a "pentadecapeptide") originally identified from a partial sequence of a protein found in gastric juice. In published in-vitro and preclinical rodent studies it has been used to investigate pathways involved in fibroblast activity, angiogenesis, nitric-oxide signaling, and the response of connective tissue in wound-healing model systems. It is commonly used in academic soft-tissue and gastrointestinal research assays to characterize cell migration, tube formation, and gene-expression endpoints. Supplied as a lyophilized powder for laboratory use. For research and analytical purposes only. Not for human or veterinary consumption. No therapeutic, diagnostic, or clinical claims are made or implied. Content pending internal legal review.
TB-500
TB-500 is a synthetic peptide corresponding to the active region of Thymosin β4, a naturally occurring actin-sequestering protein. In published in-vitro and preclinical literature it has been used as a research reagent to study actin-cytoskeleton dynamics, cell-migration assays, angiogenesis models, and endothelial and fibroblast behavior in wound-healing model systems. It is commonly used in academic cell-biology work investigating tissue-repair and vascular-remodeling endpoints. Supplied as a lyophilized powder for laboratory use. For research and analytical purposes only. Not for human or veterinary consumption. No therapeutic, diagnostic, or clinical claims are made or implied. Content pending internal legal review.